{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T16:22:56Z","timestamp":1775751776773,"version":"3.50.1"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T00:00:00Z","timestamp":1446768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0141903","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T19:03:03Z","timestamp":1446836583000},"page":"e0141903","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK\/ERK Signaling Pathway Inhibitors"],"prefix":"10.1371","volume":"10","author":[{"given":"Nora V.","family":"Lieske","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Tonby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dag","family":"Kvale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Dyrhol-Riise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjetil","family":"Tasken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,11,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","article-title":"Regulatory T cells in autoimmmunity*","volume":"18","author":"EM Shevach","year":"2000","journal-title":"Annual review of immunology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"S Sakaguchi","year":"2001","journal-title":"Immunological reviews"},{"issue":"Suppl 12","key":"ref3","first-page":"2","article-title":"Regulatory T cells and Atherosclerosis","volume":"2012","author":"JL Pastrana","year":"2012","journal-title":"Journal of clinical & experimental cardiology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3389\/fimmu.2014.00504","article-title":"T cells in vascular inflammatory diseases","volume":"5","author":"LL Lintermans","year":"2014","journal-title":"Frontiers in immunology"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"DA Vignali","year":"2008","journal-title":"Nature reviews Immunology"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.immuni.2005.01.016","article-title":"Regulatory T cell lineage specification by the forkhead transcription factor foxp3","volume":"22","author":"JD Fontenot","year":"2005","journal-title":"Immunity"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of foxp3+ T regulatory cell-mediated suppression","volume":"30","author":"EM Shevach","year":"2009","journal-title":"Immunity"},{"issue":"7130","key":"ref8","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature05478","article-title":"Foxp3 occupancy and regulation of key target genes during T-cell stimulation","volume":"445","author":"A Marson","year":"2007","journal-title":"Nature"},{"issue":"7130","key":"ref9","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nature05563","article-title":"Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells","volume":"445","author":"Y Zheng","year":"2007","journal-title":"Nature"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.4049\/jimmunol.1101804","article-title":"T cell-signaling network analysis reveals distinct differences between CD28 and CD2 costimulation responses in various subsets and in the MAPK pathway between resting and activated regulatory T cells","volume":"187","author":"ME Kalland","year":"2011","journal-title":"J Immunol"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.2276","article-title":"Immune activation and inflammation in HIV-1 infection: causes and consequences","volume":"214","author":"V Appay","year":"2008","journal-title":"The Journal of pathology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"AM Cooper","year":"2009","journal-title":"Annual review of immunology"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nri1485","article-title":"Regulatory T cells: friend or foe in immunity to infection?","volume":"4","author":"KH Mills","year":"2004","journal-title":"Nature reviews Immunology"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clim.2006.11.009","article-title":"CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease","volume":"123","author":"X Chen","year":"2007","journal-title":"Clin Immunol"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1164\/rccm.200508-1294OC","article-title":"Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis","volume":"173","author":"V Guyot-Revol","year":"2006","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2249.2006.03027.x","article-title":"A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis","volume":"144","author":"R Ribeiro-Rodrigues","year":"2006","journal-title":"Clinical and experimental immunology"},{"key":"ref17","article-title":"Increased Expression of Forkhead Box Protein 3 Gene of Regulatory T Cells in Patients with Active Tuberculosis","author":"E Beiranvand","year":"2014","journal-title":"Inflammation & allergy drug targets"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.0105-2896.2006.00412.x","article-title":"Regulatory T cells in virus infections","volume":"212","author":"BT Rouse","year":"2006","journal-title":"Immunological reviews"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/eji.200838667","article-title":"High frequency and proliferation of CD4+ FOXP3+ Treg in HIV-1-infected patients with low CD4 counts","volume":"39","author":"X Bi","year":"2009","journal-title":"European journal of immunology"},{"issue":"19","key":"ref20","doi-asserted-by":"crossref","first-page":"10262","DOI":"10.1128\/JVI.00993-12","article-title":"Homeostasis and function of regulatory T cells in HIV\/SIV infection","volume":"86","author":"ME Moreno-Fernandez","year":"2012","journal-title":"Journal of virology"},{"key":"ref21","article-title":"Global Tuberculosis Report","year":"2014"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/374786","article-title":"T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy","volume":"187","author":"PW Hunt","year":"2003","journal-title":"The Journal of infectious diseases"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrclinonc.2014.83","article-title":"The clinical development of MEK inhibitors","volume":"11","author":"Y Zhao","year":"2014","journal-title":"Nature reviews Clinical oncology"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bbamcr.2006.11.009","article-title":"Clinical experience of MEK inhibitors in cancer therapy","volume":"1773","author":"D Wang","year":"2007","journal-title":"Biochimica et biophysica acta"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1517\/13543776.2011.577068","article-title":"MEK inhibitors: a patent review 2008\u20132010","volume":"21","author":"JI Trujillo","year":"2011","journal-title":"Expert opinion on therapeutic patents"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"M Miyara","year":"2009","journal-title":"Immunity"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2217\/imt.11.168","article-title":"Immunity to TB and targets for immunotherapy","volume":"4","author":"M Gonzalez-Juarrero","year":"2012","journal-title":"Immunotherapy"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2217\/imt.10.91","article-title":"Immunotherapeutic restoration in HIV-infected individuals","volume":"3","author":"JM Kim","year":"2011","journal-title":"Immunotherapy"},{"issue":"5609","key":"ref29","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"S Hori","year":"2003","journal-title":"Science"},{"issue":"23","key":"ref30","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1182\/blood-2012-12-476218","article-title":"MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner","volume":"121","author":"T Shindo","year":"2013","journal-title":"Blood"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.4049\/jimmunol.1000202","article-title":"Signaling pathways in T follicular helper cells","volume":"184","author":"J Rolf","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/imr.12032","article-title":"Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets","volume":"252","author":"H Yamane","year":"2013","journal-title":"Immunological reviews"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.immunol.021908.132723","article-title":"Regulatory T cells in the control of host-microorganism interactions (*)","volume":"27","author":"Y Belkaid","year":"2009","journal-title":"Annual review of immunology"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-3083.2010.02496.x","article-title":"T regulatory cells and immune activation in Mycobacterium tuberculosis infection and the effect of preventive therapy","volume":"73","author":"I Wergeland","year":"2011","journal-title":"Scandinavian journal of immunology"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1164\/rccm.200701-084OC","article-title":"Regulatory T cells depress immune responses to protective antigens in active tuberculosis","volume":"176","author":"JM Hougardy","year":"2007","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20091885","article-title":"Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis","volume":"207","author":"S Shafiani","year":"2010","journal-title":"The Journal of experimental medicine"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4049\/jimmunol.178.5.2661","article-title":"Cutting Edge: Regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis","volume":"178","author":"M Kursar","year":"2007","journal-title":"J Immunol"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1182\/blood-2004-01-0365","article-title":"Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients","volume":"104","author":"L Weiss","year":"2004","journal-title":"Blood"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood-2012-07-409755","article-title":"The split personality of regulatory T cells in HIV infection","volume":"121","author":"MF Chevalier","year":"2013","journal-title":"Blood"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"e57336","DOI":"10.1371\/journal.pone.0057336","article-title":"Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells","volume":"8","author":"A Horta","year":"2013","journal-title":"PloS one"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1128\/JVI.74.6.2558-2566.2000","article-title":"Inhibition of CD3\/CD28-mediated activation of the MEK\/ERK signaling pathway represses replication of X4 but not R5 human immunodeficiency virus type 1 in peripheral blood CD4(+) T lymphocytes","volume":"74","author":"W Popik","year":"2000","journal-title":"Journal of virology"},{"issue":"10","key":"ref42","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/infdis\/jis235","article-title":"Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infection","volume":"205","author":"F Simonetta","year":"2012","journal-title":"The Journal of infectious diseases"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"e52580","DOI":"10.1371\/journal.pone.0052580","article-title":"Analysis of suppressor and non-suppressor FOXP3+ T cells in HIV-1-infected patients","volume":"7","author":"L Arruvito","year":"2012","journal-title":"PloS one"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.tube.2010.05.003","article-title":"Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis","volume":"90","author":"ND Marin","year":"2010","journal-title":"Tuberculosis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fimmu.2014.00180","article-title":"Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis","volume":"5","author":"T Prezzemolo","year":"2014","journal-title":"Frontiers in immunology"},{"issue":"12","key":"ref46","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"MR Betts","year":"2006","journal-title":"Blood"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nm.2299","article-title":"Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease","volume":"17","author":"A Harari","year":"2011","journal-title":"Nature medicine"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.4049\/jimmunol.1101122","article-title":"Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load","volume":"187","author":"CL Day","year":"2011","journal-title":"J Immunol"},{"issue":"8","key":"ref49","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/eji.201040455","article-title":"Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection","volume":"40","author":"N Caccamo","year":"2010","journal-title":"European journal of immunology"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1158\/2326-6066.CIR-13-0181","article-title":"MEK inhibition, alone or in combination with BRAF inhibition, affects multiple functions of isolated normal human lymphocytes and dendritic cells","volume":"2","author":"LJ Vella","year":"2014","journal-title":"Cancer immunology research"},{"issue":"18","key":"ref51","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1089\/088922202320935447","article-title":"Peripheral blood cell-specific cytokines in persons with untreated HIV infection in Malawi, Africa","volume":"18","author":"JA Chatt","year":"2002","journal-title":"AIDS research and human retroviruses"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2249.2001.01502.x","article-title":"T cell responses to highly active antiretroviral therapy defined by chemokine receptors expression, cytokine production, T cell receptor repertoire and anti-HIV T-lymphocyte activity","volume":"124","author":"A Giovannetti","year":"2001","journal-title":"Clinical and experimental immunology"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2249.1998.00505.x","article-title":"Abnormal intracellular IL-2 and interferon-gamma (IFN-gamma) production as HIV-1-assocated markers of immune dysfunction","volume":"111","author":"M Westby","year":"1998","journal-title":"Clinical and experimental immunology"},{"issue":"8","key":"ref54","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.bbamcr.2013.04.003","article-title":"The transcription factor NFAT1 induces apoptosis through cooperation with Ras\/Raf\/MEK\/ERK pathway and upregulation of TNF-alpha expression","volume":"1833","author":"BK Robbs","year":"2013","journal-title":"Biochimica et biophysica acta"},{"issue":"4","key":"ref55","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/aid.1991.7.375","article-title":"Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection","volume":"7","author":"M von Sydow","year":"1991","journal-title":"AIDS research and human retroviruses"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0090-1229(92)90069-Z","article-title":"TNF-alpha production by U937 promonocytes is enhanced by factors released from HIV-infected T4 lymphocytes: TNF-alpha is one of the mediators causing lysis of HIV-infected T4 cells","volume":"62","author":"D Hober","year":"1992","journal-title":"Clinical immunology and immunopathology"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2249.2003.02064.x","article-title":"Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients","volume":"131","author":"P Brazille","year":"2003","journal-title":"Clinical and experimental immunology"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/314572","article-title":"Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure","volume":"179","author":"P Aukrust","year":"1999","journal-title":"The Journal of infectious diseases"},{"issue":"18","key":"ref59","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1089\/aid.1997.13.1625","article-title":"A double-blind placebo-controlled phase II trial of thalidomide in asymptomatic HIV-positive patients: clinical tolerance and effect on activation markers and cytokines","volume":"13","author":"JB Marriott","year":"1997","journal-title":"AIDS research and human retroviruses"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/infdis\/174.4.727","article-title":"Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial","volume":"174","author":"RS Wallis","year":"1996","journal-title":"The Journal of infectious diseases"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-6405-3-8","article-title":"LMP-420, a small-molecule inhibitor of TNF-alpha, reduces replication of HIV-1 and Mycobacterium tuberculosis in human cells","volume":"3","author":"S Haraguchi","year":"2006","journal-title":"AIDS research and therapy"},{"issue":"6","key":"ref62","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/QAD.0b013e3283367836","article-title":"Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression","volume":"24","author":"L Roberts","year":"2010","journal-title":"AIDS"},{"issue":"3","key":"ref63","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-2249.2003.02307.x","article-title":"CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects","volume":"134","author":"MJ Boaz","year":"2003","journal-title":"Clinical and experimental immunology"},{"issue":"16","key":"ref64","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJMoa0903175","article-title":"Interleukin-2 therapy in patients with HIV infection","volume":"361","author":"D Abrams","year":"2009","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref65","first-page":"185","article-title":"Clinical and immune responses of tuberculosis patients treated with low-dose IL-2 and multidrug therapy","volume":"1","author":"BJ Johnson","year":"1995","journal-title":"Cytokines Mol Ther"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1164\/rccm.200211-1359OC","article-title":"Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis","volume":"168","author":"JL Johnson","year":"2003","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"2","key":"ref67","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1164\/rccm.2305001","article-title":"Immunotherapy for tuberculosis: wave of the future or tilting at windmills?","volume":"168","author":"PF Barnes","year":"2003","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"3","key":"ref68","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2013.03.022","article-title":"TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species","volume":"153","author":"FJ Roca","year":"2013","journal-title":"Cell"},{"issue":"8","key":"ref69","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/424455","article-title":"Granulomatous infections due to tumor necrosis factor blockade: correction","volume":"39","author":"RS Wallis","year":"2004","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"15","key":"ref70","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"J Keane","year":"2001","journal-title":"The New England journal of medicine"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/cei.12468","article-title":"Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection","volume":"179","author":"SL Feruglio","year":"2014","journal-title":"Clinical and experimental immunology"},{"issue":"Suppl 2","key":"ref72","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.1093\/infdis\/jis197","article-title":"Adjunct immunotherapies for tuberculosis","volume":"205","author":"M Uhlin","year":"2012","journal-title":"The Journal of infectious diseases"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0141903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T10:47:33Z","timestamp":1540032453000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0141903"}},"subtitle":[],"editor":[{"given":"Lishomwa C.","family":"Ndhlovu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,6]]},"references-count":72,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0141903","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,6]]}}}